MARX Biotech Co., Ltd. (TPEX:7731)

MARX Biotech Statistics

Total Valuation

MARX Biotech has a market cap or net worth of TWD 2.03 billion. The enterprise value is 2.38 billion.

Market Cap	2.03B
Enterprise Value	2.38B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MARX Biotech has 505.98 million shares outstanding. The number of shares has increased by 31.29% in one year.

Current Share Class	505.98M
Shares Outstanding	505.98M
Shares Change (YoY)	+31.29%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	22.98%
Owned by Institutions (%)	n/a
Float	322.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.85
PB Ratio	9.51
P/TBV Ratio	17.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.67
EV / Sales	3.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.68

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.74.

Current Ratio	1.16
Quick Ratio	0.37
Debt / Equity	1.74
Debt / EBITDA	n/a
Debt / FCF	-1.05
Interest Coverage	-8.53

Financial Efficiency

Return on equity (ROE) is -36.09% and return on invested capital (ROIC) is -10.93%.

Return on Equity (ROE)	-36.09%
Return on Assets (ROA)	-8.02%
Return on Invested Capital (ROIC)	-10.93%
Return on Capital Employed (ROCE)	-18.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	80
Asset Turnover	1.24
Inventory Turnover	1.32

Taxes

Income Tax	-3.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-57.75%
50-Day Moving Average	4.68
200-Day Moving Average	6.17
Relative Strength Index (RSI)	26.99
Average Volume (20 Days)	1,755,704

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MARX Biotech had revenue of TWD 712.87 million and -83.01 million in losses. Loss per share was -0.17.

Revenue	712.87M
Gross Profit	485.67M
Operating Income	-73.53M
Pretax Income	-86.11M
Net Income	-83.01M
EBITDA	-57.30M
EBIT	-73.53M
Loss Per Share	-0.17

Balance Sheet

The company has 27.46 million in cash and 373.00 million in debt, giving a net cash position of -345.55 million or -0.68 per share.

Cash & Cash Equivalents	27.46M
Total Debt	373.00M
Net Cash	-345.55M
Net Cash Per Share	-0.68
Equity (Book Value)	213.80M
Book Value Per Share	0.42
Working Capital	53.98M

Cash Flow

In the last 12 months, operating cash flow was -145.67 million and capital expenditures -210.49 million, giving a free cash flow of -356.16 million.

Operating Cash Flow	-145.67M
Capital Expenditures	-210.49M
Free Cash Flow	-356.16M
FCF Per Share	-0.70

Margins

Gross margin is 68.13%, with operating and profit margins of -10.31% and -11.64%.

Gross Margin	68.13%
Operating Margin	-10.31%
Pretax Margin	-12.08%
Profit Margin	-11.64%
EBITDA Margin	-8.04%
EBIT Margin	-10.31%
FCF Margin	n/a

Dividends & Yields

MARX Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.29%
Shareholder Yield	-31.29%
Earnings Yield	-4.08%
FCF Yield	-17.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 11, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jul 11, 2024
Split Type	Forward
Split Ratio	2

Scores

MARX Biotech has an Altman Z-Score of 5.12.

Altman Z-Score	5.12
Piotroski F-Score	n/a